Stay updated on Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.

Latest updates to the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check7 days agoChange DetectedThe web page has added a section with helpful links provided by the Humanitas Mirasole SpA TUDCA-ALS Consortium, enhancing the resourcefulness of the page.SummaryDifference0.4%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check36 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase III clinical trial for TUDCA in ALS patients, while retaining the mention of ALS and the EudraCT number. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference24%
- Check44 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check51 days agoChange DetectedThe web page has been updated to version 2.14.3, indicating a new revision, while the previous version 2.14.2 has been removed. Additionally, a section titled 'Helpful Links Provided by Humanitas Mirasole SpA TUDCA-ALS Consortium website' has been deleted.SummaryDifference0.6%
Stay in the know with updates to Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.